Extensive and differential platinum chemotherapy mutagenesis in children
Wenger, A.; Lee-Six, H.; Dave, M.; Layeghifard, M.; Lawson, A. R. J.; Abascal, F.; Nicola, P. A.; Treger, T. D.; Ogbonnah, T.; Parks, C.; Oliver, T. R. W.; Kennedy, J.; Hodder, A.; Anderson, N. D.; Silva, F. L. T.; Trinh, M. K.; Dowe, T.; Habarwaa, M.; Sun, J. J.; Assia-Zamora, S.; Cortes-Cerisuelo, M.; Jassem, W.; Town, C.; Dhawan, A.; Jain, V.; Straathof, K.; Deheragoda, M.; Martincorena, I.; Palm, L.; Hutchinson, J. C.; Coorens, T. H. H.; Trayers, C.; Heaton, N.; Shlien, A.; Zen, Y.; Rouhani, F. J.; Behjati, S.
Show abstract
Childhood cancer survivors often develop long-term adverse effects, which may be caused by direct mutagenesis of cytotoxic agents. Some of these agents generate distinctive DNA imprints (mutational signatures), as exemplified by platinum chemotherapeutics. Here, we examined chemotherapy mutagenesis in paediatric tissues by deploying a duplex sequencing method (NanoSeq), which enables mutation calling from single DNA molecules. We surveyed whole genomes of paediatric liver, blood and other tissues, obtained from surgical resections and at post-mortem. Platinum signatures pervaded all tissues extensively, elevating mutation burdens of paediatric tissues to levels seen in adults. Remarkably, we found a tissue-specific mutational signature in the liver. We examined the functional potential of mutations by gene focused NanoSeq, which revealed that platinum agents cause a vast repertoire of cancer causing variants across normal tissues, such as leukaemogenic mutations in blood. This finding may conceivably link cancer treatment in childhood to mutation-driven long term sequelae.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- XENTURION, a multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients for population-level translational oncology 97%
- Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer PDXs 97%
- The DiffInvex evolutionary model for conditional somatic selection identifies chemotherapy resistance genes in 10,000 cancer genomes 96%
Similar papers in this journal
Similar papers in this journal
- Cell cycle alterations associate with a redistribution of mutation rates across chromosomal domains in human cancers 96%
- Comprehensive analysis of mutational signatures in pediatric cancers 96%
- Dissecting mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damage 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.